hands of a person checking their blood glucose level with a monitor
Growing Evidence Ties COVID-19 to Diabetes Risk
Studies suggest SARS-CoV-2 infection could trigger the development of diabetes in some people, even those with no other risk factors.
ABOVE: © ISTOCK.COM, spukkato
Growing Evidence Ties COVID-19 to Diabetes Risk
Growing Evidence Ties COVID-19 to Diabetes Risk

Studies suggest SARS-CoV-2 infection could trigger the development of diabetes in some people, even those with no other risk factors.

Studies suggest SARS-CoV-2 infection could trigger the development of diabetes in some people, even those with no other risk factors.

ABOVE: © ISTOCK.COM, spukkato

beta cells

diabetes, type 1, type 2, COVID-19, SARS-CoV-2, coronavirus, pandemic, registry
A Global Registry Aims to See if COVID-19 Causes Diabetes
Asher Jones | Mar 19, 2021
Researchers have collected hundreds of COVID-19–related diabetes case reports since August of last year, in hopes of teasing apart the complex links between the two diseases.
How Breastfeeding Protects Mothers
Rachael Moeller Gorman | Jul 13, 2020
Lactation boosts the quantity and quality of insulin-producing beta cells in the pancreas, likely reducing a woman’s risk of developing type 2 diabetes.
Cell Culture Advances Fuel Disease Research
The Scientist Creative Services Team | Nov 16, 2020
New twists to an old technique reveal a better understanding of disease pathology and new therapeutic avenues.
Infographic: How Breastfeeding Protects Mothers
Rachael Moeller Gorman | Jul 13, 2020
Breastfeeding reduces type 2 diabetes risk by boosting beta cells.
type 1 diabetes
Biotechs Race to Develop Stem Cell Treatments for Diabetes
Eric Bender | Jul 15, 2019
Insulin-producing cells grown in the lab could offer a functional cure for the disease.
Studies Unable to Reproduce Results of Two Diabetes Papers
Anna Azvolinsky | Aug 10, 2018
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.
Reprogrammed Cells Treat Diabetes in Mice
Abby Olena | May 2, 2018
Researchers used a trio of transcription factors to transform pancreatic duct cells in vivo into β-like cells that secrete insulin and improve diabetes symptoms.
Gene Therapy Temporarily Reverses Type 1 Diabetes in Mice
Shawna Williams | Jan 4, 2018
Pancreatic cells engineered to produce insulin did not immediately provoke an immune response.
Immunotherapy Promising for Diabetes: Study
Aggie Mika | Aug 9, 2017
A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.
Image of the Day: Over the Islet Rainbow
The Scientist Staff | Jun 13, 2017
Scientists have constructed three-dimensional maps depicting the size and location of insulin-producing islet cells in the mouse pancreas.
Bioengineered ‘Pancreas’ Effective in First Patient
Aggie Mika | May 11, 2017
The diabetic volunteer continued to produce insulin one year after she received a transplant of abdominal islet cells.
High-Profile Diabetes Study Retracted
Joshua A. Krisch | Dec 28, 2016
The results, which could not be replicated, suggested that a hormone increased pancreatic β cell proliferation, supplanting insulin as a front-line diabetes treatment in mice.
How High Fat and Insulin Levels May Lead to Diabetes
Barbara E. Corkey | Jun 30, 2016
Lipids and insulin play important roles in blood sugar regulation, and altered levels of either could kick start metabolic dysfunction.
Insulin-Producing Mini Stomachs
Catherine Offord | Feb 21, 2016
Scientists grow gastric organs in vitro that can restore insulin production when transplanted into mice.
Diabetes “Breakthrough” Breaks Up
Kerry Grens | Oct 27, 2014
A hormone thought to make murine insulin-secreting cells proliferate in mice did not perform in replication studies.
Lab-Made Insulin-Secreting Cells
Bob Grant | Oct 13, 2014
Researchers craft hormone-producing pancreas cells from human embryonic stem cells, paving the way for a cell therapy to treat diabetes.